Share
PrintTest Details
Cancer Type
Breast, Breast Cancer, Colorectal cancer (CRC), Gastric, Liver, Lung, Non-small cell lung cancer, Ovarian, Pan-cancer, Pancreatic, Prostate
Turnaround Time
7 - 10 days
Use
The Labcorp Plasma Focus test is a Next Generation Sequencing-based laboratory-developed test (LDT) for the detection of genomic sequence mutations in 33 clinically actionable or relevant genes, including amplifications in eight genes, translocations associated with five genes and microsatellite instability (MSI) using plasma derived cell DNA (cfDNA). The test is intended to be used by qualified health care professionals in accordance with professional oncology guidelines for patients with advanced stage or metastatic non small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, gastroesophageal junction cancer, gastric cancer or melanoma. Test results are not prescriptive for the use of any specific therapeutic product.
Special Instructions
Specimens must be submitted using the Liquid Biopsy Specimen Kit and shipped directly to the PGDx lab location, using the shipping label provided in the kit.
Methodology
Next Generation Sequencing
Specimen Requirements
Information on collection, storage, and volume
Specimen
Whole blood
Volume
2 tubes of 10 mL each
Minimum Volume
2 tubes of 10 mL each
Container
Liquid Biopsy Specimen Kit (PeopleSoft No. 137408)
Storage Instructions
Maintain at room temperature after collection and during shipping.
Causes for Rejection
Samples not collected and submitted in Streck tubes; specimens submitted in expired or incorrect blood tubes; quantity not sufficient for analysis; specimens received more than seven days from collection; frozen specimens
Collection
Collect 10 mL of whole blood into each of 2 Streck BCT tubes supplied in the Liquid Biopsy Specimen Kit. Only the Liquid Biopsy Specimen Kit can be used for collection.
